Stockscreener 앱 받기
1.75
1.74%
0.03
시간 외 거래:
1.75
전일 마감가:
$1.72
열려 있는:
$1.7
하루 거래량:
19,894
Relative Volume:
0.29
시가총액:
$89.10M
수익:
$63.69M
순이익/손실:
$-44.82M
주가수익비율:
-0.875
EPS:
-2
순현금흐름:
$-30.56M
1주 성능:
-2.78%
1개월 성능:
+18.24%
6개월 성능:
-15.46%
1년 성능:
-44.27%
1일 변동 폭
$1.67
$1.76
1주일 범위
$1.67
$1.88
52주 변동 폭
$1.35
$3.50
Mdxhealth Sa Stock (MDXH) Company Profile
MDXH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
1.75 | 89.10M | 63.69M | -44.82M | -30.56M | -2.00 |
|
TMO
Thermo Fisher Scientific Inc
|
422.27 | 159.05B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
197.40 | 140.21B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
475.07 | 34.90B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
108.37 | 30.47B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
152.30 | 26.47B | 15.41B | 1.37B | 2.11B | 7.50 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-31 | 개시 | Lake Street | Buy |
| 2023-05-31 | 개시 | TD Cowen | Outperform |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
Mdxhealth Sa 주식(MDXH)의 최신 뉴스
MDxHealth Schedules Key Shareholders’ Meetings for May 2025 - TipRanks
Global Molecular Diagnostics Market to Expand at a CAGR of ~9% by 2032 Due to the Rising Demand for Precision Medicine | DelveInsight - GlobeNewswire Inc.
Mdxhealth to Release First Quarter 2025 Financial Results on May 14 - The Manila Times
MDxHealth SA Announces Promising Research Results with New Liquid Biopsy Test in Development - marketscreener.com
Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.
Bleichroeder LP's Strategic Acquisition of MDxHealth SA Shares - GuruFocus
MDxHealth SA (NASDAQ:MDXH) Short Interest Up 133.8% in February - Defense World
Oppenheimer & Co. Inc. Has $47,000 Holdings in MDxHealth SA (NASDAQ:MDXH) - Defense World
MDxHealth CEO acquires company shares worth $80,000 By Investing.com - Investing.com Australia
MDxHealth stock hits 52-week low at $1.49 amid market challenges - Investing.com Canada
MDxHealth stock hits 52-week low at $1.49 amid market challenges By Investing.com - Investing.com South Africa
MDxHealth CEO acquires company shares worth $80,000 - Investing.com India
Down -15.22% in 4 Weeks, Here's Why You Should You Buy the Dip in MDxHealth SA (MDXH) - Yahoo Finance
Research Analysts Issue Forecasts for MDxHealth Q1 Earnings - Defense World
What is William Blair’s Forecast for MDxHealth Q1 Earnings? - Defense World
MDxHealth SA (MDXH) Reports Q4 Loss, Tops Revenue Estimates - MSN
MDxHealth SA (NASDAQ:MDXH) Q3 2024 Earnings Call Transcript - MSN
Mdxhealth S.A. Reports Strong Revenue Growth in Earnings Call - TipRanks
MDxHealth (NASDAQ:MDXH) Issues Earnings Results, Beats Estimates By $0.07 EPS - MarketBeat
MDxHealth SA (NASDAQ:MDXH) Q4 2024 Earnings Call Transcript - Insider Monkey
Mdxhealth fourth quarter revenue grows 28% to USD 24.7M - Medical Buyer
MDxHealth SA (MDXH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Challenges - Yahoo Finance
MDxHealth ADR earnings beat by $0.05, revenue topped estimates - Investing.com South Africa
MDxHealth SA reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: MDxHealth beats Q4 2024 EPS forecast, stock rises - Investing.com
Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results - The Manila Times
Earnings Flash (MDXH) MDxHealth SA Reports Q4 Revenue $24.7M, vs. FactSet Est of $23.3M - Marketscreener.com
Can MDxHealth's 28% Revenue Growth Finally Deliver Profitability in 2025? - StockTitan
MDxHealth SA expected to post a loss of 19 cents a shareEarnings Preview - TradingView
MDxHealth (MDXH) Projected to Post Earnings on Wednesday - Defense World
Mdxhealth to Present Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on February 26 - The Manila Times
MDxHealth Earnings Alert: Key Financial Results & Strategic Updates Unveiled Next Week - Stock Titan
MDxHealth's study on assureMDx published in Journal of Urology - Reuters.com
MDxHealth SA Provides Revenue Guidance for the Fourth Quarter of 2024, Full Year of 2024 and Year 2025 - Marketscreener.com
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance - The Manila Times
MDxHealth Reports Strong 28% Revenue Growth, Projects EBITDA Profitability in 2025 - StockTitan
Contrasting Biodesix (NASDAQ:BDSX) & MDxHealth (NASDAQ:MDXH) - Defense World
Critical Survey: BioNexus Gene Lab (NASDAQ:BGLC) versus MDxHealth (NASDAQ:MDXH) - Defense World
MDxHealth: Strong Buy On Its Cutting-Edge Urology Diagnostics (NASDAQ:MDXH) - Seeking Alpha
MDxHealth (STU:O6C1) Enterprise Value : €88.51 Mil (As of Dec. 08, 2024) - GuruFocus.com
MDxHealth (CHIX:MDXHB) Enterprise Value : €102.00 Mil (As of Dec. 01, 2024) - GuruFocus.com
MDxHealth to Participate in Piper Sandler Healthcare Conference - The Manila Times
MDxHealth CEO to Present at Piper Sandler Healthcare Conference in NYC | MDXH Stock News - StockTitan
OneDigital Investment Advisors LLC Increases Stock Position in MDxHealth SA (NASDAQ:MDXH) - Defense World
MVM Partners, LLC Reduces Stake in Paragon 28 Inc - GuruFocus.com
MDxHealth SA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
MDxHealth stock hits 52-week low at $1.57 amid market challenges By Investing.com - Investing.com South Africa
Mdxhealth Sa (MDXH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.34%
0.46%
자본화:
|
볼륨(24시간):